188 related articles for article (PubMed ID: 18458473)
1. Poly(lactic acid) (PLA) based nanocomposites--a novel way of drug-releasing.
Chen C; Lv G; Pan C; Song M; Wu C; Guo D; Wang X; Chen B; Gu Z
Biomed Mater; 2007 Dec; 2(4):L1-4. PubMed ID: 18458473
[TBL] [Abstract][Full Text] [Related]
2. Enhanced anti-topoisomerase II activity by mucoadhesive 4-CBS-chitosan/poly (lactic acid) nanoparticles.
Songsurang K; Suvannasara P; Phurat C; Puthong S; Siraleartmukul K; Muangsin N
Carbohydr Polym; 2013 Nov; 98(2):1335-42. PubMed ID: 24053811
[TBL] [Abstract][Full Text] [Related]
3. Poly(lactic acid)/chitosan hybrid nanoparticles for controlled release of anticancer drug.
Wang W; Chen S; Zhang L; Wu X; Wang J; Chen JF; Le Y
Mater Sci Eng C Mater Biol Appl; 2015 Jan; 46():514-20. PubMed ID: 25492016
[TBL] [Abstract][Full Text] [Related]
4. Preparation of Polymeric Prodrug Paclitaxel-Poly(lactic acid)-b-Polyisobutylene and Its Application in Coatings of a Drug Eluting Stent.
Ren K; Zhang M; He J; Wu Y; Ni P
ACS Appl Mater Interfaces; 2015 Jun; 7(21):11263-71. PubMed ID: 25955234
[TBL] [Abstract][Full Text] [Related]
5. Layer-by-layer polyelectrolyte coating of low molecular weight poly(lactic acid) nanoparticles.
Hirsjärvi S; Peltonen L; Hirvonen J
Colloids Surf B Biointerfaces; 2006 Apr; 49(1):93-9. PubMed ID: 16616460
[TBL] [Abstract][Full Text] [Related]
6. [Drug release properties of sodium alginate hydrophobically modified by star polylactic acid].
Ma FW; Jin Y; Zhang WF; Zhou SB; Ni CH
Yao Xue Xue Bao; 2010 Nov; 45(11):1447-51. PubMed ID: 21361047
[TBL] [Abstract][Full Text] [Related]
7. A modified double-emulsion method for the preparation of daunorubicin-loaded polymeric nanoparticle with enhanced in vitro anti-tumor activity.
Liu J; Qiu Z; Wang S; Zhou L; Zhang S
Biomed Mater; 2010 Dec; 5(6):065002. PubMed ID: 20924138
[TBL] [Abstract][Full Text] [Related]
8. Poly(lactic acid)/TiO₂ nanocomposites as alternative biocidal and antifungal materials.
Fonseca C; Ochoa A; Ulloa MT; Alvarez E; Canales D; Zapata PA
Mater Sci Eng C Mater Biol Appl; 2015 Dec; 57():314-20. PubMed ID: 26354270
[TBL] [Abstract][Full Text] [Related]
9. Nanoparticles of poly(D,L-lactide)/methoxy poly(ethylene glycol)-poly(D,L-lactide) blends for controlled release of paclitaxel.
Dong Y; Feng SS
J Biomed Mater Res A; 2006 Jul; 78(1):12-9. PubMed ID: 16596586
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and characterization of tumor-targeted copolymer nanocarrier modified by transferrin.
Liu R; Wang Y; Li X; Bao W; Xia G; Chen W; Cheng J; Xu Y; Guo L; Chen B
Drug Des Devel Ther; 2015; 9():2705-19. PubMed ID: 26045659
[TBL] [Abstract][Full Text] [Related]
11. Novel Strategy to Fabricate PLA/Au Nanocomposites as an Efficient Drug Carrier for Human Leukemia Cells in Vitro.
Li J; Chen C; Wang X; Gu Z; Chen B
Nanoscale Res Lett; 2011 Dec; 6(1):29. PubMed ID: 27502652
[TBL] [Abstract][Full Text] [Related]
12. Development of poly(lactic acid) nanostructured membranes for the controlled delivery of progesterone to livestock animals.
Oliveira JE; Medeiros ES; Cardozo L; Voll F; Madureira EH; Mattoso LH; Assis OB
Mater Sci Eng C Mater Biol Appl; 2013 Mar; 33(2):844-9. PubMed ID: 25427496
[TBL] [Abstract][Full Text] [Related]
13. The drug encapsulation efficiency, in vitro drug release, cellular uptake and cytotoxicity of paclitaxel-loaded poly(lactide)-tocopheryl polyethylene glycol succinate nanoparticles.
Zhang Z; Feng SS
Biomaterials; 2006 Jul; 27(21):4025-33. PubMed ID: 16564085
[TBL] [Abstract][Full Text] [Related]
14. Reversible targeting and controlled release delivery of daunorubicin to cancer cells by aptamer-wrapped carbon nanotubes.
Taghdisi SM; Lavaee P; Ramezani M; Abnous K
Eur J Pharm Biopharm; 2011 Feb; 77(2):200-6. PubMed ID: 21168488
[TBL] [Abstract][Full Text] [Related]
15. Fabrication of aligned poly(lactic acid)-chitosan nanofibers by novel parallel blade collector method for skin tissue engineering.
Shalumon KT; Sathish D; Nair SV; Chennazhi KP; Tamura H; Jayakumar R
J Biomed Nanotechnol; 2012 Jun; 8(3):405-16. PubMed ID: 22764409
[TBL] [Abstract][Full Text] [Related]
16. Methoxy poly(ethylene glycol)-poly(lactide) (MPEG-PLA) nanoparticles for controlled delivery of anticancer drugs.
Dong Y; Feng SS
Biomaterials; 2004 Jun; 25(14):2843-9. PubMed ID: 14962562
[TBL] [Abstract][Full Text] [Related]
17. Blends of TiO2 nanoparticles and poly (N-isopropylacrylamide)-co-polystyrene nanofibers as a means to promote the biorecognition of an anticancer drug.
Song M; Pan C; Li J; Zhang R; Wang X; Gu Z
Talanta; 2008 May; 75(4):1035-40. PubMed ID: 18585180
[TBL] [Abstract][Full Text] [Related]
18. Vitamin E TPGS-emulsified poly(lactic-co-glycolic acid) nanoparticles for cardiovascular restenosis treatment.
Feng SS; Zeng W; Teng Lim Y; Zhao L; Yin Win K; Oakley R; Hin Teoh S; Hang Lee RC; Pan S
Nanomedicine (Lond); 2007 Jun; 2(3):333-44. PubMed ID: 17716178
[TBL] [Abstract][Full Text] [Related]
19. Novel PLA modification of organic microcontainers based on ring opening polymerization: synthesis, characterization, biocompatibility and drug loading/release properties.
Efthimiadou EK; Tziveleka LA; Bilalis P; Kordas G
Int J Pharm; 2012 May; 428(1-2):134-42. PubMed ID: 22402473
[TBL] [Abstract][Full Text] [Related]
20. The release behavior of doxorubicin hydrochloride from medicated fibers prepared by emulsion-electrospinning.
Xu X; Chen X; Ma P; Wang X; Jing X
Eur J Pharm Biopharm; 2008 Sep; 70(1):165-70. PubMed ID: 18472256
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
